Physical performance measures for predicting outcome in cancer patients: a systematic review

Acta Oncologica

Volumn 55, Issue 12, 2016, Pages 1386-1391

  Verweij, Norbert M ^a   Schiphorst, Anandi H W ^a   Pronk, Apollo ^a   van den Bos, Frederiek ^b   Hamaker, Marije E ^a  

^a DEPARTMENT OF SURGERY   (Netherlands)

^b HAGA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; CANCER PATIENT; CLINICAL ASSESSMENT; CLINICAL OUTCOME; GAIT; HUMAN; PHYSICAL PERFORMANCE; PREDICTION; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SHORT PHYSICAL PERFORMANCE BATTERY TEST; SURVIVAL; SYSTEMATIC REVIEW; TIMED UP AND GO TEST; ADULT; AGED; DISABILITY; GERIATRIC ASSESSMENT; HEALTH STATUS; MIDDLE AGED; MORTALITY; NEOPLASMS; PREDICTIVE VALUE; PSYCHOMOTOR PERFORMANCE; SURVIVAL RATE;

ADULT; AGED; DISABILITY EVALUATION; GERIATRIC ASSESSMENT; HEALTH STATUS; HUMANS; MIDDLE AGED; NEOPLASMS; PREDICTIVE VALUE OF TESTS; PSYCHOMOTOR PERFORMANCE; SURVIVAL RATE;

EID: 84997079461     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/0284186X.2016.1219047     Document Type: Review

References (47)

1. Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents:a worldwide population-based study (CONCORD). Lancet Oncol 2008;9:730–56.
2. Active early detection colon cancer programs:“Rijksinstituut voor Volksgezondheid en Milieu”, bevolkingsonderzoek darmkanker [Internet]. [cited 2014 Feb 1]. Available from:http://www.RIVM.nl
3. Jemal A, Bray F, Center MM, et al. Global Cancer Statistics:2011. CA Cancer J Clin 2011;61:69–90.
4. Bretthauer M., Colorectal cancer screening. Journal of Internal Medicine 2011;270:87–98.
5. Hewitson P, Glasziou P, Irwig L, et al. Screening for colorectal cancer using the fecal occult blood test, Hemoccult. Cochrane Database Syst Rev 2007;24:CD001216.
6. Comparetto C, Borruto F., Cervical cancer screening:a never-ending developing program. World J Clin Cases 2015;3:614–24.
7. Bretthauer M, Kalager M., Principles, effectiveness and caveats in screening for cancer. Br J Surg 2013;100:55–65. Vol.
8. Netherlands Cancer registry [Internet]. [cited 2015 Jan 1]. Available from:www.cijfersoverkanker.nl
9. Hamaker ME, Prins MC, Schiphorst AH, et al. Long-term changes in physical capacity after colorectal cancer treatment. J Geriatr Oncol 2015;6:153–64.
10. Verweij NM, Schiphorst A, Pronk A, et al. Conventional and laparoscopic colon resections in the elderly. World J Color Surg 2015;5:3
11. Hamaker ME, van Rixtel B, Thunnissen P, et al. Multidisciplinary decision-making on chemotherapy for colorectal cancer:an age-based comparison. J Geriatr Oncol 2015;6:225–32.
12. Hamaker ME, Vos AG, Smorenburg CH, et al. The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancer. The Oncologist 2012;17:1439–49.
13. Brunello A, Sandri R, Extermann M., Multidimensional geriatric evaluation for older cancer patients as a clinical and research tool. Cancer Treat Rev 2009;35:487–92.
14. Extermann M, Hurria A., Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol 2007;25:1824–31.
15. Wells GA, Shea B, O ’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in metaanalysis. 2014; [Internet]. Available from:http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
16. Biesma B, Wymenga AN, Vincent A, et al. Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel:NVALT-3 a phase III study. Ann Oncol 2011;22:1520–7.
17. Cerullo F, Coloca G, Ferini A, et al. Misure di funzione fisica in oncogeriatria. G Gerontol 2011;59:265–72.
18. Cesari M, Cerullo F, Zamboni V, et al. Functional status and mortality in older women with gynecological cancer. J Gerontol a Biol Sci Med Sci 2013;68:1129–33.
19. Dale W, Hemmerich J, Kamm A, et al. Geriatric assessment improves prediction of surgical outcomes in older adults undergoing pancreaticoduodenectomy:a prospective cohort study. Ann Surg 2014;259:960–5.
20. Deschler B, Ihorst G, Platzbecker U, et al. Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome. Haematologica 2013;98:208–16.
21. Hamaker ME, Mitrovic M, Stauder R., The G8 screening tool detects relevant geriatric impairments and predicts survival in elderly patients with a haematological malignancy. Ann Hematol 2014;93:1031–40.
22. Honecker FU, Wedding U, Rettig K, et al. Use of the Comprehensive Geriatric Assessment (CGA) in elderly patients (pts) with solid tumors to predict mortality. J Clin Oncol 2009;27:9549.
23. Hoppe S, Rainfray M, Fonck M, et al. Functional decline in older patients with cancer receiving first-line chemotherapy. J Clin Oncol 2013;31:3877–82.
24. Huisman MG, Van Leeuwen BL, Ugolini G, et al. “Timed Up & Go”:a screening tool for predicting 30-day morbidity in onco-geriatric surgical patients? A multicenter cohort study. PLoS One 2014;9:e86863.
25. Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer:a prospective multicenter study. J Clin Oncol 2011;29:3457–65.
26. Kanesvaran R, Li H, Koo K-N, et al. Analysis of prognostic factors of comprehensive geriatric assessment and development of a clinical scoring system in elderly asian patients with cancer. J Clin Oncol 2011;29:3620–7.
27. Klepin HD, Geiger AM, Tooze J, et al. Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia. Blood 2013;121:4287–94.
28. Klepin HD, Geiger AM, Tooze J, et al. Physical performance and subsequent disability and survival in older adults with malignancy:results from the health, aging and body composition study. J Am Geriatr Soc 2010;58:76–82.
29. Muffly L, Kocherginsky M, Stock W, et al. Geriatric Assessment (GA) to predict survival in older allogeneic Hematopoietic Cell Transplantation (HCT) recipients. Biol Blood Marrow Transplant 2014;20:S39–S40.
30. Ramsdale E, Bylow K, Polite B, et al. Relationship between components of the Comprehensive Geriatric Assessment (CGA), chemotherapy dose intensity and overall survival in a colorectal cancer (CRC) cohort age 65 and over. J Am Geriatr Soc 2012;60:S2.
31. Soubeyran P, Fonck M, Blanc-Bisson C, et al. Predictors of early death risk in older patients treated with first-line chemotherapy for cancer. J Clin Oncol 2012;30:1829–34.
32. Hamaker ME, Prins MC, Stauder R., The relevance of a geriatric assessment for elderly patients with a haematological malignancy:a systematic review. Leuk Res 2014;38:275–83.
33. Hackett NJ, De Oliveira GS, Jain UK, et al. ASA class is a reliable independent predictor of medical complications and mortality following surgery. Int J Surg 2015;18:184–90.
34. Terret C, Albrand G, Moncenix G, et al. Karnofsky Performance Scale (KPS) or Physical Performance Test (PPT)? That is the question. Critic Rev Oncol Hematol 2011;77:142–7.
35. Park C-M, Koh Y, Jeon K, et al. Impact of Eastern cooperative oncology group performance status on hospital mortality in critically ill patients. J Crit Care 2014;29:409–13.
36. Owusua C, Koroukianb SM, Schluchter M, et al. Screening older cancer patients for a Comprehensive Geriatric Assessment:A comparison of three instruments. J Geriatr Oncol 2011;2:121–9.
37. Wildiers H, Heeren P, Puts M, et al. International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol 2014;32:2595–603.
38. Extermann M, Aapro M, Bernabei R, et al. Use of comprehensive geriatric assessment in older cancer patients:Recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 2005;55:241–52.
39. Cesari M, Kritchevsky SB, Newman AB, et al. Added value of physical performance measures in predicting adverse health-related events:results from the Health, Aging And Body Composition Study. J Am Geriatr Soc 2009;57:251–9.
40. Studenski S, Perera S, Patel K., Gait speed and survival in older adults. JAMA 2011;305:50–8.
41. Stanaway FF, Gnjidic D, Blyth FM, et al. How fast does the Grim Reaper walk? Receiver operating characteristics curve analysis in healthy men aged 70 and over. BMJ 2011;343:d7679.
42. Cesari M, Kritchevsky SB, Penninx BWHJ, et al. Prognostic value of usual gait speed in well-functioning older people–results from the Health, Aging and Body Composition Study. J Am Geriatr Soc 2005;53:1675–80.
43. Keeler E, Guralnik JM, Tian H, et al. The impact of functional status on life expectancy in older persons. Journals Gerontol - Ser a Biol Sci Med Sci 2010;65 A:727–33.
44. Augschoell J, Kemmler G, Hamaker ME, et al. PPT and VES-13 in elderly patients with cancer:Evaluation in multidimensional geriatric assessment and prediction of survival. J Geriatr Oncol 2014;5:415–21.
45. Reuben DB, Siu AL., An objective measure of physical function of elderly outpatients. The physical performance test. J Am Geriatr Soc 1990;38:1105–12.
46. Podsiadlo D, Richardson S., The timed “Up & Go”:a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991;39:142–8.
47. Guralnik JM, Ferrucci L, Simonsick EM, et al. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 1995;332:556–61.